RESILIENCE helps you survive cancer with a strong heart

Patient encounter: stories of resilience and improvement

Since we started the RESILIENCE project, we have held regular encounters with our patients, and family members who wish to attend, along with members of our team. We believe these gatherings are a fruitful experience in which they have the chance of sharing their needs with us so we may get to know aspects to […]

Doctor Alberto López answers your questions about cardiovascular health

Due to the commemoration of the European Day for the Prevention of Cardiovascular Risk on March 14th we have launched a campaign on our Instagram to collect your questions and concerns about this topic. Doctor Alberto López, member of our RESILIENCE team, have answered them. Dr. López is an expert in Hematology at the Hospital […]

Amsterdam UMC Hospital joins RESILIENCE

It is a great satisfaction for us to announce the incorporation of the Amsterdam UMC Hospital to the RESILIENCE project on November 8th. Amsterdam UMC is one of the largest academic hospitals in the Netherlands and consists of 2 centers: The Amsterdam UMC located at the AMC (Academic Medical Center) and the Amsterdam UMC, located […]

Puerta de Hierro University Hospital joins RESILIENCE

On October 23rd, Puerta de Hierro Majadahonda University Hospital joined the RESILIENCE project, so hopefully it will begin to incorporate patients into the trial in the coming days. This hospital was created in 1964 and, since then, it has fulfilled a triple function: care, teaching and research. Currently, as a public institution dependent on the […]

Heart failure may no longer be a death sentence for cancer survivors

Cancer patients receiving anthracycline chemotherapy have more than twice the risk of developing heart failure compared to their peers without cancer. The ground-breaking RESILIENCE project aims to prevent heart failure in patients who need anthracyclines to treat their cancer. International experts and patients from the project gathered on October 19th at the European Heart House, […]

Science and Innovation Week

On Thursday, November 16th at 19:00 hours we will organize the “RESILIENCE Workshop and laboratory visit. Surviving cancer with a strong heart” within the activities held in Madrid on the occasion of the Science and Innovation Week. The “RESILIENCE Workshop and laboratory visit. Surviving cancer with a strong heart” will consist of a free activity, for the public of all ages, […]

Building a career as a cardiovascular investigator

During the Global Cardio Oncology Summit 2023, that took place in Madrid last September 27th, we had the opportunity of listening  Dr. Borja Ibáñez, coordinator of  RESILIENCE project and Scientific Director of CNIC, discussing with Dr. Bonnie Ky, Director of the Penn Center for Quantitative Echocardiography and Thalheimer Center for Cardio-Oncology and editor-in-chief of JACC: […]

Join us at the European Heart House in Nice for the RESILIENCE multi-stakeholder event: Survive cancer with a strong heart

The European Society of Cardiology (ESC) through the ESC Council of Cardio-Oncology will host on October 19th the first multi-stakeholder meeting in the context the RESILIENCE project, funded by the European Commission, to share the latest results with different stakeholders and patients. The event will focus on emerging therapies for cancer therapy induced cardiotoxicity and […]

RESILIENCE participates in the European Researchers Night in Madrid

RESILIENCE Project will participate on Friday, September 29th in the XIV European Researchers Night in Madrid with an activity in which the public of all ages can attend, free of charge, with prior registration. The “RESILIENCE Workshop and laboratory visit. Surviving cancer with a strong heart” where we will have the opportunity of getting closer […]

RESILIENCE broadens the spectrum of patients who may benefit from entering the trial

The RESILIENCE trial has expanded its inclusion criteria to allow more types of lymphoma to be included in the trial. These changes are proposed after having agreed with the recruiting hospitals. To date, only patients with a specific type of lymphoma (non-Hodgkin) were included, but after a careful study by the research team, it has […]

Logotipo Resilience

Are you a patient participating in RESILIENCE? Here you will find useful information about the details of your participation, activities specifically designed for you. You will also be able to contact RESILIENCE researchers.

In accordance with the provisions of Regulation (EU) 2016/679 on the protection of personal data of natural persons (GDPR), the personal information you have provided will be incorporated into the data processing systems of the Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) for the purpose of attending your registration application in the restricted area for patients participating in the RESILIENCE study. The legal basis for processing your personal data for this purpose is your explicit consent. Your personal data will not be disclosed to any recipients other than those to whom you authorise or when required by law to do so. You may exercise your rights of access, right to rectification, to object, to erasure, to restriction of processing, data portability and not to be subject to automated individual decision-making. To exercise these rights, as well as to obtain additional information about the processing of your personal data, you can consult the following link Terms and Conditions